  RECORD TYPE: PRESIDENTIAL   (NOTES MAIL)

  CREATOR: Christopher C. Jennings ( CN=Christopher C. Jennings/OU=OPD/O=EOP [ OPD 1 )

  CREATION DATE/TIME:15-AUG-1997 18:41:34_00

  SUBJECT:   weekly

  TO: Laura Emmett ( CN=Laura Emmett/OU=WHO/O=EOP @ EOP   [ WHO 1 )
  READ: UNKNOWN

  TO: Elena Kagan ( CN=Elena Kagan/OU=OPD/O=EOP @ EOP [ OPD 1 )
  READ: UNKNOWN

  TEXT:
  ==================== ATTACHMENT   1 ====================
  ATT CREATION TIME/DATE:   0 00:00:00.00

  TEXT:
  Unable to convert ARMS_EXT: [ATTACH_D181MAIL486776620.216 to ASCII,
   The following is a HEX DUMP:

  FF57504370040000010A020100000002050000004FOB000000020000AD7AAE2F669417C2E6DD69
  9FDA05142B684A2B6C5F29897EA584C1D9FD7E46C7145586E1338E9CD6B1AA3CF020BB735E90CA
  93DC8DF882423B265379DB02C76F967A63FA6FB8997C320AF557CO9E1FBDE7FFF027095ACC1153
  SA574BF09171E72B40D364DDDB1EC13246F9C31ECBE5C3A18D3E047D93016AB710BC627956FCF9
  4B3EBE97DE7242AD462EDB4CCF73BC5241892BB264D21AFD191A02A3872B01AA9269525680CB55
  8B881FC14D8BF1615F1005EE04COCF8D67664D1368DB96EC467EC82AA89414A78697337A7946C7
  1365FAA17F0515E3D6D933CA9B7CEFF5E17BFE55A2E35844D46BBC841CCBB02A55BDC7D23E72E4
  9CD47FD83A36C3C6778849B072744FAF96A28B4FCB26650AEOF88D34237794EE63BBF45A9E9FBB
  F0229040A596B72CFE8C26EOD8CE5370618BAOB2E353F73531402F49B86A05CA7CDECF65107364
  BE0690D296663D55B57B26B6D9ECE1888497271C24587C09BDE1C3679FD6D0453DC7DACFED2E62
  A93DB558CBB6B515DBCDCF534AC49587E3238762439315313D57B7850A2544639DB4057F803359
  7E19B33A698344A4CB8E3F819DB61B2C8BOC48E81B73188B2D1FFA4E1296DE16A3FC72B1E208A2
  3CD8016DB5A02DE6EB891D02212CF5BC9EF4DOFBCCE97050C482FCA80BE1F6DAEA11B81AB75715
  65CFC7BE9A02000900000000000000000000000823010000000B0100007E020000005501000000
  4E0000008903000009250100000006000000D70300000B300200000028000000DD030000087701
  000000400000000504000008340100000014000000450400000802010000000F00000059040000
  080501000000080000006804000000984800500020004C0061007300650072004A006500740020
  003500000000000000000000000000000000000000000000000000000000000000000000000000
  00000000000000000000000057494E53504F4F4COOOOOOOOOOC800C8002C012C012C012C01C800
  C80030000000000000000000000000000000000000000000000000000000000000000000000000
  000000000000000000000000000000000000000000000000000000000000000000000000000000
  000000000000000000000000000000000000000000000000000000000000000000000000000000
  000000000000000000000000000000000000000000000000000000000000000000000000000000
  000000005E008FOE2800D61EC30F3908000011090000005AOOOB01008B143600540069006D0065
  00730020004E0065007700200052006F006D0061006E00200052006500670075006C0061007200
  000000000000000001000200580201000000040028000000000000000000000000000000000000
  00011202002400A1000000A10000000AOOOOOOF00001004500F10002000200F20001004500F300
  02000200F40001004500F50001000200F6000B006581F70001000200F80002007B03F900010045
  00AE5EFD220000000070005800440064007000380008337C00780001020000F900000003010004
  0002000000DDOA10008301040003000200211000DDDDOBOB00030000040BOODDF102F600F19BF1
  03F600F1F20CF2CCCC464441805265666F726D805570646174652E808080F30CF3546865804164
  6D696E697374726174696F6E2C804D656D62657273806F6680436F6E67726573732C8061738077
  656C6C80617380746865DOO1l500000B000900018806D801020001201500D0706861726D616365
  75746963616C80696E6475737472792C8061726580686F70696E6780746861748061806D757475
  616C6C798061636365707461626C658061677265656D656E748063616E80626580726561636865
  64806561726C79CF746869738046616C6C806F6E8074686580464441807265666F726D8062696C
  6C2E80805265736F6C7574696F6E806F6E80746869738069737375658069738063726974696361
  6C80746F8074686580696E64757374727980616E648074686580464441CF626563617573658069
                                                                     Hex-Dump Conversion
FDA Reform Update. The Administration, Members of Congress, as well as the
phannaceutical industry, are hoping that a mutually acceptable agreement can be reached early
this Fall on the FDA refonn bill. Resolution on this issue is critical to the industry and the FDA
because it includes the reauthorization ofPDUFA, the Prescription Drug User Fee Act. This
legislation continues the successful user fee program that has produced additional resources for
FDA to expedite reviews and approvals of new drugs. It has been extremely successful program
and, without reauthorization, a 60-day notice oflay-offwill be sent to personnel doing reviews
on October 1st. There are only a few outstanding non-prescription drug issues, including some
technical issues dealing with devices, environmental impact issues, budgeting issues, and the one
Senator Kennedy mentioned to you recently -- the Federal pre-emption state regulation of
cosmetics, which would prohibit state regulation of perfumes, creams, etc. Almost all efforts to
date to pass this legislation have taken place in the Senate, but the time pressure of the impending
lay-offs is expected to provide an incentive for the House to start moving. HHS will be meeting
with both Senate and House representatives next week and early in September to push both sides
to pass an acceptable bill that you can sign into law hopefully sometime in October.
        ARMS                                                                         Page I of2


